Aminopeptidase N inhibitor
This page covers all Aminopeptidase N inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Aminopeptidase N.
Targets
Phase 3 pipeline (1)
- SPD476 (mesalazine) · Shire · Gastroenterology
SPD476 (mesalazine) works by inhibiting the enzyme aminopeptidase N to reduce inflammation in the gut.
Patent intelligence
- aminopeptidase n inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates